Literature DB >> 18083280

Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression.

Agnieszka Szuster-Ciesielska1, Maria Słotwińska, Anna Stachura, Halina Marmurowska-Michałowska, Halina Dubas-Slemp, Agnieszka Bojarska-Junak, Martyna Kandefer-Szerszeń.   

Abstract

Acceleration of blood leukocyte apoptosis in major depression has been described. The present studies have been undertaken to estimate the level of apoptosis of blood leukocytes in patients with depression and to examine the mechanisms leading to apoptosis. Blood was taken from 29 patients with depression (age 48.2+/-11.2, 14 males, 15 females) and 30 healthy controls (age 41.3+/-4.1, 15 males, 15 females), and apoptosis was estimated by the cytometric method by measurements of annexin V binding, mitochondrial membrane potential (DeltaPsi), bcl-2, bax, and Fas (CD95) expression in CD4+, CD8+ and CD14+ cells. The amounts of cytochrome c released from mitochondria to cytosol of peripheral blood mononuclear cells (PBMCs) and polymorphonuclear cells (PMNs) were also measured. The levels of reactive oxygen species (ROS) released from PMNs were examined as was the serum activity of superoxide dismutase (SOD), catalase (CAT), and total peroxidase (PER). Additionally, serum levels of the tumor necrosis factor (TNF-alpha) and interleukin-6 (IL-6) were estimated. Our experiments indicated accelerated apoptosis of CD4+ T lymphocytes and CD14+ cells (mainly neutrophils) of depressed patients as well as a significant increase in the percent of Fas-expressing cells. Bcl-2 and bax expression was higher in cells of depressed patients than in control, however, bcl-2/bax ratio was significantly decreased in CD14+ cells of depressed patients. PMNs isolated from the blood of the patients produced more ROS spontaneously and after induction with phorbol ester (PMA) than PMNs of the healthy control. A significant increase in serum activity of SOD, CAT and PER was also detected. Overproduction of superoxide anion correlated positively with the level of PMNs apoptosis (measured by cytochrome c release), suggesting that superoxide anion might be an important factor inducing apoptotic death of blood cells. The result of our experiment indicated that apoptosis of immune cells may affect patient's susceptibility to different infections and application of antioxidants in medication of patients with depression will be beneficial for them. The increased level of IL-6 in sera of the depressed patients did not correlate with overproduction of ROS, suggesting that this cytokine is not involved in oxidative stress and apoptosis of leukocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18083280     DOI: 10.1016/j.pnpbp.2007.11.012

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  32 in total

Review 1.  Antioxidants as antidepressants: fact or fiction?

Authors:  Giovanni Scapagnini; Sergio Davinelli; Filippo Drago; Antonino De Lorenzo; Giovannangelo Oriani
Journal:  CNS Drugs       Date:  2012-06-01       Impact factor: 5.749

Review 2.  Immune system to brain signaling: neuropsychopharmacological implications.

Authors:  Lucile Capuron; Andrew H Miller
Journal:  Pharmacol Ther       Date:  2011-02-17       Impact factor: 12.310

3.  Putative role of intracellular Zn(2+) release during oxidative stress: a trigger to restore cellular thiol content that is decreased by oxidative stress.

Authors:  Akio Kinazaki; Hongqin Chen; Kazuki Koizumi; Takuya Kawanai; Tomohiro M Oyama; Masaya Satoh; Shiro Ishida; Yoshiro Okano; Yasuo Oyama
Journal:  J Physiol Sci       Date:  2011-07-10       Impact factor: 2.781

Review 4.  Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior.

Authors:  Ebrahim Haroon; Charles L Raison; Andrew H Miller
Journal:  Neuropsychopharmacology       Date:  2011-09-14       Impact factor: 7.853

5.  Antioxidant-like effects and protective action of transcranial magnetic stimulation in depression caused by olfactory bulbectomy.

Authors:  Inmaculada Tasset; René Drucker-Colín; José Peña; Ignacio Jimena; Pedro Montilla; Francisco Javier Medina; Isaac Túnez
Journal:  Neurochem Res       Date:  2010-04-29       Impact factor: 3.996

Review 6.  An Act of Balance Between Adaptive and Maladaptive Immunity in Depression: a Role for T Lymphocytes.

Authors:  Catherine Toben; Bernhard T Baune
Journal:  J Neuroimmune Pharmacol       Date:  2015-07-02       Impact factor: 4.147

7.  The protective effects of resveratrol on social stress-induced cytokine release and depressive-like behavior.

Authors:  Julie E Finnell; Calliandra M Lombard; Michael N Melson; Narendra P Singh; Mitzi Nagarkatti; Prakash Nagarkatti; James R Fadel; Christopher S Wood; Susan K Wood
Journal:  Brain Behav Immun       Date:  2016-08-31       Impact factor: 7.217

8.  Augmentation therapy with alpha-lipoic acid and desvenlafaxine: a future target for treatment of depression?

Authors:  Márcia Calheiros Chaves Silva; Caren Nádia Soares de Sousa; Luis Rafael Leite Sampaio; Naiara Coelho Ximenes; Paulo Victor Pontes Araújo; Jéssica Calheiros da Silva; Suzyana Lima de Oliveira; Francisca Cléa Florenço Sousa; Danielle Silveira Macêdo; Silvânia Maria Mendes Vasconcelos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-16       Impact factor: 3.000

Review 9.  Depression and immunity: a role for T cells?

Authors:  Andrew H Miller
Journal:  Brain Behav Immun       Date:  2009-10-08       Impact factor: 7.217

10.  Multisystem resiliency moderates the major depression-telomere length association: findings from the Heart and Soul Study.

Authors:  Eli Puterman; Elissa S Epel; Jue Lin; Elizabeth H Blackburn; James J Gross; Mary A Whooley; Beth E Cohen
Journal:  Brain Behav Immun       Date:  2013-05-30       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.